Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC35A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYRM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEZT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC26A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBCCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUP58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIPRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on